| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.713 | 0.022 | 0.713 | Caspase 9 stimulant | 0.665 0.028 CID_154699859 | ||
| 0.689 | 0.005 | 0.781 | Histamine release inhibitor | 0.781 0.004 CID_154699859 | CID_154699859 | |
| 0.658 | 0.039 | 0.815 | Antiinflammatory | 0.815 0.013 CID_154699859 | CID_154699859 | |
| 0.625 | 0.023 | 0.817 | Cyclophilin D inhibitor | 0.817 0.006 CID_154699859 | CID_154699859 | |
| 0.561 | 0.014 | 0.723 | Antioxidant | 0.723 0.005 CID_154699859 | CID_154699859 | |
| 0.518 | 0.005 | 0.537 | Lipid peroxidase inhibitor | 0.537 0.005 CID_154699859 | CID_154699859 | |
| 0.532 | 0.023 | 0.532 | 5 Hydroxytryptamine release inhibitor | 0.503 0.031 CID_154699859 | ||
| 0.54 | 0.039 | 0.802 | Transcription factor NF kappa B inhibitor | 0.802 0.013 CID_154699859 | CID_154699859 | |
| 0.507 | 0.018 | 0.507 | Lipoxygenase inhibitor | 0.178 0.167 CID_154699859 | ||
| 0.476 | 0.036 | 0.637 | Cholesterol antagonist | 0.637 0.014 CID_154699859 | CID_154699859 | |
| 0.457 | 0.02 | 0.673 | Hypoglycemic | 0.673 0.005 CID_154699859 | CID_154699859 | |
| 0.472 | 0.04 | 0.472 | Calcium channel L-type activator | |||
| 0.423 | 0.021 | 0.542 | Interleukin 2 agonist | 0.542 0.005 CID_154699859 | CID_154699859 | |
| 0.42 | 0.023 | 0.49 | Platelet antagonist | 0.49 0.015 CID_154699859 | CID_154699859 | |
| 0.415 | 0.026 | 0.615 | Free radical scavenger | 0.615 0.008 CID_154699859 | CID_154699859 | |
| 0.414 | 0.046 | 0.745 | Antithrombotic | 0.745 0.006 CID_154699859 | CID_154699859 | |
| 0.383 | 0.015 | 0.583 | Non-steroidal antiinflammatory agent | 0.583 0.005 CID_154699859 | CID_154699859 | |
| 0.386 | 0.023 | 0.386 | Peroxidase inhibitor | |||
| 0.452 | 0.091 | 0.631 | Apoptosis agonist | 0.631 0.043 CID_154699859 | CID_154699859 | |
| 0.367 | 0.01 | 0.501 | NOS3 expression enhancer | 0.501 0.005 CID_154699859 | CID_154699859 | |
| 0.405 | 0.058 | 0.405 | Toll-Like receptor agonist | 0.252 0.146 CID_154699859 | ||
| 0.402 | 0.059 | 0.402 | Toll-Like receptor 7 agonist | 0.222 0.176 CID_154699859 | ||
| 0.353 | 0.012 | 0.353 | Protein kinase stimulant | 0.315 0.015 CID_154699859 | ||
| 0.333 | 0.005 | 0.333 | Prostaglandin antagonist | 0.087 0.02 CID_154699859 | ||
| 0.384 | 0.061 | 0.384 | Vasodilator, peripheral | 0.308 0.093 CID_154699859 | ||
| 0.376 | 0.057 | 0.611 | Immunostimulant | 0.611 0.015 CID_154699859 | CID_154699859 | |
| 0.344 | 0.031 | 0.513 | Interleukin agonist | 0.513 0.008 CID_154699859 | CID_154699859 | |
| 0.322 | 0.012 | 0.322 | Insulin sensitizer | 0.286 0.019 CID_154699859 | ||
| 0.344 | 0.037 | 0.397 | Hypolipemic | 0.397 0.026 CID_154699859 | CID_154699859 | |
| 0.357 | 0.052 | 0.555 | Vasodilator, coronary | 0.555 0.01 CID_154699859 | CID_154699859 | |
| 0.355 | 0.053 | 0.53 | Apoptosis antagonist | 0.53 0.017 CID_154699859 | CID_154699859 | |
| 0.318 | 0.016 | 0.567 | Monophenol monooxygenase inhibitor | 0.567 0.006 CID_154699859 | CID_154699859 | |
| 0.31 | 0.011 | 0.446 | Insulin secretagoues | 0.446 0.005 CID_154699859 | CID_154699859 | |
| 0.338 | 0.048 | 0.338 | Sodium/bile acid cotransporter inhibitor | 0.295 0.084 CID_154699859 | ||
| 0.343 | 0.056 | 0.343 | Aldehyde oxidase inhibitor | |||
| 0.289 | 0.004 | 0.289 | Potassium channel large-conductance Ca-activated activator | 0.198 0.007 CID_154699859 | ||
| 0.288 | 0.007 | 0.288 | Histidine decarboxylase inhibitor | |||
| 0.271 | 0.006 | 0.271 | Potassium channel (Ca-activated) activator | 0.204 0.014 CID_154699859 | ||
| 0.268 | 0.004 | 0.302 | Interferon agonist | 0.302 0.003 CID_154699859 | CID_154699859 | |
| 0.258 | 0.005 | 0.258 | Photosensitizer | 0.252 0.006 CID_154699859 | ||
| 0.259 | 0.012 | 0.402 | Expectorant | 0.402 0.005 CID_154699859 | CID_154699859 | |
| 0.246 | 0.006 | 0.246 | NAD(P)H dehydrogenase (quinone) inhibitor | |||
| 0.276 | 0.037 | 0.493 | Hepatoprotectant | 0.493 0.007 CID_154699859 | CID_154699859 | |
| 0.264 | 0.024 | 0.41 | Amylase inhibitor | 0.41 0.009 CID_154699859 | CID_154699859 | |
| 0.246 | 0.007 | 0.246 | Mucolytic | 0.191 0.015 CID_154699859 | ||
| 0.252 | 0.017 | 0.252 | Cholesterol synthesis inhibitor | 0.224 0.022 CID_154699859 | ||
| 0.255 | 0.022 | 0.323 | Alpha-N-acetylglucosaminidase inhibitor | 0.323 0.014 CID_154699859 | CID_154699859 | |
| 0.245 | 0.013 | 0.245 | Neurotrophic factor | 0.215 0.021 CID_154699859 | ||
| 0.256 | 0.025 | 0.256 | Cyclooxygenase inhibitor | 0.18 0.05 CID_154699859 | ||
| 0.256 | 0.029 | 0.263 | Protein-tyrosine phosphatase inhibitor | 0.263 0.027 CID_154699859 | CID_154699859 | |
| 0.258 | 0.034 | 0.258 | Neurotrophic factor enhancer | 0.172 0.107 CID_154699859 | ||
| 0.225 | 0.005 | 0.238 | Leukotriene antagonist | 0.238 0.004 CID_154699859 | CID_154699859 | |
| 0.243 | 0.023 | 0.243 | Cyclooxygenase 1 inhibitor | 0.185 0.041 CID_154699859 | ||
| 0.229 | 0.009 | 0.229 | Porphobilinogen synthase inhibitor | |||
| 0.27 | 0.057 | 0.27 | Gastrin inhibitor | 0.269 0.059 CID_154699859 | ||
| 0.231 | 0.019 | 0.231 | 5-Lipoxygenase inhibitor | |||
| 0.295 | 0.085 | 0.563 | Immunomodulator | 0.563 0.015 CID_154699859 | CID_154699859 | |
| 0.218 | 0.012 | 0.613 | Mediator release inhibitor | 0.613 0.004 CID_154699859 | CID_154699859 | |
| 0.22 | 0.017 | 0.22 | Arachidonic acid antagonist | 0.174 0.06 CID_154699859 | ||
| 0.264 | 0.062 | 0.399 | Vasodilator | 0.399 0.023 CID_154699859 | CID_154699859 | |
| 0.258 | 0.06 | 0.258 | Tyrosine 3 hydroxylase inhibitor | |||
| 0.22 | 0.023 | 0.22 | Aldehyde dehydrogenase inhibitor | 0.132 0.06 CID_154699859 | ||
| 0.243 | 0.054 | 0.243 | RNA-directed DNA polymerase inhibitor | 0.184 0.125 CID_154699859 | ||
| 0.228 | 0.048 | 0.228 | Dual specificity phosphatase 3 inhibitor | |||
| 0.235 | 0.056 | 0.438 | Nitric oxide antagonist | 0.438 0.021 CID_154699859 | CID_154699859 | |
| 0.264 | 0.085 | 0.378 | Spasmolytic | 0.378 0.045 CID_154699859 | CID_154699859 | |
| 0.214 | 0.036 | 0.214 | Phospholipase C inhibitor | 0.18 0.061 CID_154699859 | ||
| 0.213 | 0.036 | 0.291 | Melanin inhibitor | 0.291 0.023 CID_154699859 | CID_154699859 | |
| 0.214 | 0.039 | 0.214 | Succinate dehydrogenase inhibitor | |||
| 0.246 | 0.072 | 0.667 | Angiogenesis stimulant | 0.667 0.005 CID_154699859 | CID_154699859 | |
| 0.179 | 0.004 | 0.21 | Interferon inducer | 0.21 0.003 CID_154699859 | CID_154699859 | |
| 0.203 | 0.028 | 0.235 | Protein-tyrosine phosphatase 1B inhibitor | 0.235 0.02 CID_154699859 | CID_154699859 | |
| 0.202 | 0.03 | 0.202 | Cyclooxygenase 2 inhibitor | 0.146 0.057 CID_154699859 | ||
| 0.249 | 0.082 | 0.249 | 5 Hydroxytryptamine uptake stimulant | |||
| 0.181 | 0.019 | 0.181 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.129 0.034 CID_154699859 | ||
| 0.256 | 0.095 | 0.256 | Hypoxia-inducible factor 1 alpha inhibitor | 0.241 0.109 CID_154699859 | ||
| 0.188 | 0.027 | 0.188 | Cystathionine beta-synthase inhibitor | 0.126 0.054 CID_154699859 | ||
| 0.223 | 0.063 | 0.223 | Anesthetic general | 0.205 0.072 CID_154699859 | ||
| 0.243 | 0.084 | 0.29 | DNA damaging | 0.29 0.061 CID_154699859 | CID_154699859 | |
| 0.2 | 0.042 | 0.2 | Phospholipase A2 inhibitor | 0.179 0.055 CID_154699859 | ||
| 0.235 | 0.078 | 0.31 | DNA synthesis inhibitor | 0.31 0.04 CID_154699859 | CID_154699859 | |
| 0.181 | 0.024 | 0.313 | Xanthine oxidase inhibitor | 0.313 0.007 CID_154699859 | CID_154699859 | |
| 0.218 | 0.062 | 0.434 | Platelet adhesion inhibitor | 0.434 0.009 CID_154699859 | CID_154699859 | |
| 0.172 | 0.017 | 0.172 | Carbonic anhydrase VI inhibitor | |||
| 0.169 | 0.015 | 0.253 | Triose-phosphate isomerase inhibitor | 0.253 0.007 CID_154699859 | CID_154699859 | |
| 0.163 | 0.009 | 0.168 | Aldose reductase inhibitor | 0.168 0.009 CID_154699859 | CID_154699859 | |
| 0.266 | 0.113 | 0.266 | Thyroid hormone antagonist | |||
| 0.203 | 0.053 | 0.203 | Dual specificity phosphatase inhibitor | |||
| 0.19 | 0.045 | 0.331 | Interferon gamma antagonist | 0.331 0.016 CID_154699859 | CID_154699859 | |
| 0.227 | 0.083 | 0.423 | Antiamyloidogenic | 0.423 0.025 CID_154699859 | CID_154699859 | |
| 0.183 | 0.04 | 0.183 | Mannose-6-phosphate isomerase inhibitor | 0.172 0.048 CID_154699859 | ||
| 0.212 | 0.07 | 0.212 | Nitric-oxide synthase stimulant | |||
| 0.274 | 0.132 | 0.508 | Immunosuppressant | 0.508 0.031 CID_154699859 | CID_154699859 | |
| 0.146 | 0.005 | 0.204 | Leukotriene B4 antagonist | 0.204 0.004 CID_154699859 | CID_154699859 | |
| 0.153 | 0.014 | 0.153 | Keratolytic | |||
| 0.157 | 0.018 | 0.157 | DOPA decarboxylase inhibitor | |||
| 0.149 | 0.013 | 0.149 | Peroxisome proliferator-activated receptor gamma agonist | 0.1 0.028 CID_154699859 | ||
| 0.183 | 0.047 | 0.183 | MAO inhibitor | |||
| 0.156 | 0.021 | 0.211 | Uric acid excretion stimulant | 0.211 0.012 CID_154699859 | CID_154699859 | |
| 0.203 | 0.069 | 0.203 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | |||
| 0.135 | 0.004 | 0.135 | Prostaglandin D2 antagonist | |||
| 0.158 | 0.027 | 0.158 | Ca2+-transporting ATPase inhibitor | 0.157 0.028 CID_154699859 | ||
| 0.134 | 0.004 | 0.134 | Retinoid X alpha receptor agonist | |||
| 0.158 | 0.031 | 0.158 | Vanilloid 1 agonist | 0.134 0.059 CID_154699859 | ||
| 0.15 | 0.026 | 0.15 | Adenylate kinase inhibitor | 0.113 0.05 CID_154699859 | ||
| 0.259 | 0.137 | 0.259 | Calcium channel activator | |||
| 0.141 | 0.02 | 0.141 | ABCA1 expression enhancer | |||
| 0.151 | 0.032 | 0.151 | Sphingosine 1-phosphate receptor 4 antagonist | |||
| 0.159 | 0.041 | 0.259 | Cyclooxygenase 3 inhibitor | 0.259 0.008 CID_154699859 | CID_154699859 | |
| 0.161 | 0.048 | 0.161 | NADPH oxidase inhibitor | 0.127 0.075 CID_154699859 | ||
| 0.153 | 0.04 | 0.153 | MAO A inhibitor | |||
| 0.122 | 0.01 | 0.122 | Maillard reaction inhibitor | 0.076 0.026 CID_154699859 | ||
| 0.13 | 0.019 | 0.13 | Ornithine decarboxylase inhibitor | |||
| 0.126 | 0.018 | 0.126 | HIV-1 integrase (3'-Processing) inhibitor | 0.094 0.028 CID_154699859 | ||
| 0.132 | 0.024 | 0.132 | Cathepsin G inhibitor | |||
| 0.234 | 0.129 | 0.234 | Thyroid hormone beta antagonist | |||
| 0.15 | 0.046 | 0.155 | Antibacterial (Helicobacter pylori) | 0.155 0.042 CID_154699859 | CID_154699859 | |
| 0.134 | 0.032 | 0.134 | HIV-1 integrase (Overall Integration) inhibitor | |||
| 0.227 | 0.125 | 0.227 | 12-Lipoxygenase inhibitor | |||
| 0.105 | 0.004 | 0.105 | Leukotriene C antagonist | 0.062 0.026 CID_154699859 | ||
| 0.104 | 0.004 | 0.104 | Retinoid X receptor agonist | |||
| 0.116 | 0.018 | 0.116 | HIV-1 integrase (Strand Transfer) inhibitor | 0.088 0.028 CID_154699859 | ||
| 0.136 | 0.04 | 0.136 | GABA C receptor agonist | |||
| 0.226 | 0.135 | 0.372 | Caspase 3 stimulant | 0.372 0.053 CID_154699859 | CID_154699859 | |
| 0.136 | 0.046 | 0.245 | DNA repair enzyme inhibitor | 0.245 0.005 CID_154699859 | CID_154699859 | |
| 0.129 | 0.04 | 0.129 | Estrogen antagonist | 0.104 0.088 CID_154699859 | ||
| 0.15 | 0.062 | 0.15 | Adenylate cyclase stimulant | |||
| 0.136 | 0.047 | 0.239 | Topoisomerase I inhibitor | 0.239 0.019 CID_154699859 | CID_154699859 | |
| 0.148 | 0.06 | 0.148 | Bone formation stimulant | 0.127 0.079 CID_154699859 | ||
| 0.141 | 0.054 | 0.242 | Topoisomerase II inhibitor | 0.242 0.026 CID_154699859 | CID_154699859 | |
| 0.127 | 0.04 | 0.127 | Carbonic anhydrase III inhibitor | |||
| 0.218 | 0.131 | 0.218 | Insulysin inhibitor | |||
| 0.108 | 0.022 | 0.108 | Leukotriene synthesis inhibitor | |||
| 0.158 | 0.071 | 0.214 | Diuretic | 0.214 0.039 CID_154699859 | CID_154699859 | |
| 0.119 | 0.033 | 0.119 | Estrogen receptor beta antagonist | |||
| 0.172 | 0.088 | 0.187 | P-glycoprotein inhibitor | 0.187 0.074 CID_154699859 | CID_154699859 | |
| 0.114 | 0.031 | 0.114 | Phosphodiesterase 4D inhibitor | |||
| 0.124 | 0.041 | 0.251 | UDP-glucose 4-epimerase inhibitor | 0.251 0.013 CID_154699859 | CID_154699859 | |
| 0.115 | 0.032 | 0.115 | Carbonic anhydrase XIII inhibitor | |||
| 0.101 | 0.019 | 0.101 | Prostaglandin EP2 antagonist | 0.087 0.023 CID_154699859 | ||
| 0.141 | 0.059 | 0.141 | Toll-Like receptor 2 antagonist | |||
| 0.098 | 0.017 | 0.098 | Peroxisome proliferator-activated receptor gamma antagonist | |||
| 0.166 | 0.085 | 0.166 | Lipocortins synthesis antagonist | 0.147 0.109 CID_154699859 | ||
| 0.11 | 0.031 | 0.11 | Bile acid receptor antagonist | |||
| 0.253 | 0.174 | 0.623 | Antibacterial | 0.623 0.016 CID_154699859 | CID_154699859 | |
| 0.085 | 0.006 | 0.085 | Liver X receptor alpha agonist | |||
| 0.08 | 0.004 | 0.08 | Leukotriene C4 antagonist | 0.041 0.023 CID_154699859 | ||
| 0.126 | 0.05 | 0.126 | Ferrochelatase inhibitor | |||
| 0.078 | 0.005 | 0.145 | Cytokine production stimulant | 0.145 0.003 CID_154699859 | CID_154699859 | |
| 0.082 | 0.01 | 0.082 | DNA helicase inhibitor | 0.062 0.026 CID_154699859 | ||
| 0.088 | 0.017 | 0.088 | Glutamate (mGluR6) antagonist | |||
| 0.107 | 0.037 | 0.266 | NADH dehydrogenase inhibitor | 0.266 0.007 CID_154699859 | CID_154699859 | |
| 0.105 | 0.036 | 0.105 | Interleukin 5 antagonist | 0.08 0.073 CID_154699859 | ||
| 0.105 | 0.037 | 0.198 | Topoisomerase II alpha inhibitor | 0.198 0.015 CID_154699859 | CID_154699859 | |
| 0.1 | 0.032 | 0.166 | Phosphofructokinase-1 inhibitor | 0.166 0.015 CID_154699859 | CID_154699859 | |
| 0.117 | 0.049 | 0.117 | Carbonic anhydrase XV inhibitor | |||
| 0.074 | 0.007 | 0.074 | Leukotriene D4 antagonist | 0.044 0.011 CID_154699859 | ||
| 0.234 | 0.169 | 0.234 | GABA C receptor rho-3 antagonist | |||
| 0.112 | 0.047 | 0.112 | Creatine kinase inhibitor | |||
| 0.096 | 0.032 | 0.096 | Glutamate decarboxylase inhibitor | |||
| 0.126 | 0.063 | 0.199 | Alkylator | 0.199 0.027 CID_154699859 | CID_154699859 | |
| 0.08 | 0.018 | 0.08 | Peroxisome proliferator-activated receptor alpha agonist | 0.042 0.04 CID_154699859 | ||
| 0.099 | 0.038 | 0.099 | Glutathione S-transferase inhibitor | |||
| 0.132 | 0.074 | 0.132 | Alkaline phosphatase inhibitor | 0.125 0.08 CID_154699859 | ||
| 0.091 | 0.034 | 0.091 | Estrogen receptor alpha antagonist | |||
| 0.125 | 0.07 | 0.125 | Papain-like protease (SARS coronavirus) inhibitor | |||
| 0.107 | 0.053 | 0.107 | Anabolic | |||
| 0.069 | 0.016 | 0.069 | CD45 antagonist | |||
| 0.059 | 0.009 | 0.059 | Retinoic acid alpha receptor agonist | 0.037 0.032 CID_154699859 | ||
| 0.057 | 0.009 | 0.057 | Liver X receptor beta agonist | |||
| 0.054 | 0.007 | 0.054 | Free fatty acid receptor 1 antagonist | |||
| 0.104 | 0.058 | 0.104 | MAO B inhibitor | |||
| 0.069 | 0.024 | 0.069 | Prostaglandin E2 antagonist | |||
| 0.056 | 0.011 | 0.056 | Peroxisome proliferator-activated receptor delta agonist | |||
| 0.094 | 0.049 | 0.214 | Antineoplastic antibiotic | 0.214 0.019 CID_154699859 | CID_154699859 | |
| 0.05 | 0.006 | 0.05 | Liver X receptor alpha antagonist | |||
| 0.083 | 0.04 | 0.083 | CDC25A inhibitor | |||
| 0.053 | 0.009 | 0.053 | Prostaglandin agonist | |||
| 0.103 | 0.06 | 0.103 | Bronchodilator | |||
| 0.051 | 0.008 | 0.051 | Vanilloid 3 antagonist | |||
| 0.06 | 0.018 | 0.074 | Glucose-6-phosphate isomerase inhibitor | 0.074 0.011 CID_154699859 | CID_154699859 | |
| 0.05 | 0.008 | 0.05 | Liver X receptor beta antagonist | |||
| 0.114 | 0.073 | 0.114 | Adenylate cyclase inhibitor | |||
| 0.074 | 0.033 | 0.074 | NMDA receptor agonist | |||
| 0.063 | 0.023 | 0.063 | Thromboxane synthase inhibitor | |||
| 0.078 | 0.038 | 0.078 | Carbonic anhydrase VA inhibitor | |||
| 0.082 | 0.043 | 0.082 | Glutamate dehydrogenase inhibitor | |||
| 0.107 | 0.068 | 0.107 | Chelator | |||
| 0.049 | 0.01 | 0.049 | Liver X receptor antagonist | |||
| 0.06 | 0.022 | 0.06 | Topoisomerase II beta inhibitor | |||
| 0.103 | 0.067 | 0.335 | AMP-activated protein kinase stimulant | 0.335 0.004 CID_154699859 | CID_154699859 | |
| 0.049 | 0.013 | 0.049 | Retinoid X receptor antagonist | |||
| 0.046 | 0.011 | 0.046 | Peroxisome proliferator-activated receptor delta antagonist | |||
| 0.069 | 0.034 | 0.087 | Nitric oxide donor | 0.087 0.017 CID_154699859 | CID_154699859 | |
| 0.054 | 0.02 | 0.054 | Liver X receptor agonist | |||
| 0.068 | 0.033 | 0.068 | Aminopeptidase microsomal inhibitor | |||
| 0.059 | 0.025 | 0.219 | Heparanase inhibitor | 0.219 0.002 CID_154699859 | CID_154699859 | |
| 0.04 | 0.006 | 0.04 | Thyroid hormone agonist | |||
| 0.073 | 0.04 | 0.073 | Carbonic anhydrase V inhibitor | |||
| 0.069 | 0.035 | 0.069 | Protease activated receptor antagonist | |||
| 0.067 | 0.034 | 0.067 | Purinergic P2X1 antagonist | |||
| 0.134 | 0.101 | 0.138 | Heat shock protein 70 antagonist | 0.138 0.083 CID_154699859 | CID_154699859 | |
| 0.075 | 0.042 | 0.075 | HIV-1 integrase inhibitor | |||
| 0.043 | 0.011 | 0.043 | ATP citrate lysase inhibitor | |||
| 0.043 | 0.012 | 0.043 | Retinoid X alpha receptor antagonist | |||
| 0.066 | 0.035 | 0.066 | Biliverdin reductase inhibitor | |||
| 0.064 | 0.034 | 0.064 | Argininosuccinate synthase inhibitor | |||
| 0.081 | 0.05 | 0.111 | Na+ K+ transporting ATPase inhibitor | 0.111 0.022 CID_154699859 | CID_154699859 | |
| 0.041 | 0.01 | 0.041 | Prostaglandin EP4 antagonist | |||
| 0.071 | 0.041 | 0.071 | Glutamate (mGluR7) antagonist | |||
| 0.04 | 0.012 | 0.04 | Leukotriene B4 receptor 1 antagonist | 0.037 0.013 CID_154699859 | ||
| 0.049 | 0.022 | 0.055 | Guanylate cyclase inhibitor | 0.055 0.016 CID_154699859 | CID_154699859 | |
| 0.032 | 0.007 | 0.032 | Prostaglandin EP4 agonist | |||
| 0.122 | 0.098 | 0.122 | Farnesoid X receptor antagonist | |||
| 0.084 | 0.061 | 0.121 | Transcription factor NF kappa B stimulant | 0.121 0.025 CID_154699859 | CID_154699859 | |
| 0.1 | 0.076 | 0.1 | Protein kinase (CK2) alpha inhibitor | |||
| 0.115 | 0.092 | 0.171 | Interleukin 4 antagonist | 0.171 0.034 CID_154699859 | CID_154699859 | |
| 0.081 | 0.058 | 0.081 | Ca(v)3.1 blocker | |||
| 0.032 | 0.01 | 0.032 | Prostaglandin E2 agonist | |||
| 0.088 | 0.067 | 0.102 | Alcohol dehydrogenase inhibitor | 0.102 0.05 CID_154699859 | CID_154699859 | |
| 0.046 | 0.024 | 0.046 | Sphingosine 1-phosphate receptor 1 agonist | |||
| 0.092 | 0.071 | 0.092 | Electrolyte absorption antagonist | |||
| 0.029 | 0.009 | 0.033 | Leukotriene B4 receptor 2 antagonist | 0.033 0.007 CID_154699859 | CID_154699859 | |
| 0.059 | 0.039 | 0.059 | Xanthine dehydrogenase inhibitor | |||
| 0.074 | 0.054 | 0.079 | GABA aminotransferase inhibitor | 0.079 0.047 CID_154699859 | CID_154699859 | |
| 0.046 | 0.028 | 0.046 | Sphingosine 1-phosphate receptor agonist | |||
| 0.102 | 0.084 | 0.102 | TRPA1 agonist | |||
| 0.137 | 0.12 | 0.187 | DNA methyltransferase I inhibitor | 0.187 0.076 CID_154699859 | CID_154699859 | |
| 0.049 | 0.031 | 0.049 | Carnitine palmitoyltransferase 1B inhibitor | |||
| 0.089 | 0.073 | 0.089 | Aminopeptidase B inhibitor | |||
| 0.052 | 0.036 | 0.052 | Aconitate hydratase inhibitor | |||
| 0.061 | 0.045 | 0.061 | NMDA receptor glycine site agonist | |||
| 0.028 | 0.012 | 0.028 | Peroxisome proliferator-activated receptor alpha antagonist | |||
| 0.024 | 0.008 | 0.024 | Free fatty acid receptor 1 agonist | |||
| 0.048 | 0.034 | 0.048 | Aminopeptidase N inhibitor | |||
| 0.091 | 0.077 | 0.091 | GABA C receptor rho-1 antagonist | |||
| 0.047 | 0.033 | 0.047 | Adenosine deaminase inhibitor | |||
| 0.021 | 0.007 | 0.021 | Thyroid hormone alpha antagonist | |||
| 0.053 | 0.039 | 0.053 | Thromboxane antagonist | |||
| 0.026 | 0.012 | 0.026 | Retinoic acid receptor agonist | |||
| 0.15 | 0.136 | 0.15 | Aryl hydrocarbon receptor agonist | |||
| 0.061 | 0.048 | 0.348 | Selectin antagonist | 0.348 0.004 CID_154699859 | CID_154699859 | |
| 0.021 | 0.009 | 0.021 | G-protein-coupled receptor 120 agonist | |||
| 0.139 | 0.128 | 0.256 | DNA methylase inhibitor | 0.256 0.045 CID_154699859 | CID_154699859 | |
| 0.087 | 0.076 | 0.087 | Interleukin 1 beta converting enzyme inhibitor | |||
| 0.036 | 0.025 | 0.036 | Glutamate (mGluR8) antagonist | |||
| 0.052 | 0.042 | 0.052 | Sphingosine 1-phosphate receptor 5 agonist | |||
| 0.038 | 0.028 | 0.038 | Urate transporter 1 inhibitor | |||
| 0.062 | 0.053 | 0.062 | Sphingosine 1-phosphate receptor 4 agonist | |||
| 0.022 | 0.013 | 0.022 | Retinoid X beta receptor agonist | |||
| 0.037 | 0.029 | 0.037 | Glutamate (mGluR8) agonist | |||
| 0.052 | 0.045 | 0.052 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.05 0.048 CID_154699859 | ||
| 0.139 | 0.132 | 0.139 | I kappa B kinase epsilon inhibitor | |||
| 0.025 | 0.018 | 0.025 | Lysophosphatidic acid receptor 1 agonist | |||
| 0.047 | 0.041 | 0.047 | Lysophosphatidic acid 3 receptor antagonist | |||
| 0.023 | 0.017 | 0.023 | Retinoid X gamma receptor agonist | |||
| 0.034 | 0.029 | 0.034 | 5-Alpha-reductase inhibitor | |||
| 0.029 | 0.024 | 0.029 | Prostaglandin D2 agonist | |||
| 0.03 | 0.025 | 0.03 | Prostacyclin antagonist | |||
| 0.039 | 0.034 | 0.039 | Angiotensin AT1 receptor antagonist | |||
| 0.02 | 0.015 | 0.02 | Retinoid X beta receptor antagonist | |||
| 0.124 | 0.12 | 0.124 | Mcl-1 antagonist | |||
| 0.166 | 0.162 | 0.166 | Superoxide dismutase inhibitor | |||
| 0.023 | 0.02 | 0.023 | Glutamate (mGluR1) agonist | |||
| 0.016 | 0.012 | 0.016 | Thyroid hormone alpha agonist | |||
| 0.049 | 0.046 | 0.049 | Carbonic anhydrase VB inhibitor | |||
| 0.045 | 0.042 | 0.045 | Bombesin 2 receptor antagonist | |||
| 0.056 | 0.053 | 0.056 | Bcl-xL inhibitor | |||
| 0.015 | 0.012 | 0.015 | Prostacyclin agonist | |||
| 0.029 | 0.027 | 0.029 | Elastase 3B inhibitor | |||
| 0.029 | 0.027 | 0.029 | Elastase 2B inhibitor | |||
| 0.029 | 0.027 | 0.029 | Elastase 3A inhibitor | |||
| 0.042 | 0.041 | 0.047 | Estrogen agonist | 0.047 0.037 CID_154699859 | CID_154699859 | |
| 0.053 | 0.051 | 0.053 | Carbamoyl phosphate synthetase inhibitor | |||
| 0.049 | 0.047 | 0.049 | Alcohol oxidase inhibitor | |||
| 0.062 | 0.061 | 0.062 | Prostaglandin-E synthase inhibitor | |||
| 0.017 | 0.017 | 0.039 | Antibiotic Anthracycline-like | 0.039 0.002 CID_154699859 | CID_154699859 | |
| 0.08 | 0.081 | 0.087 | Thioredoxin inhibitor | 0.087 0.067 CID_154699859 | CID_154699859 | |
| 0.126 | 0.129 | 0.176 | Amyloid beta aggregation inhibitor | 0.176 0.091 CID_154699859 | CID_154699859 | |
| 0.081 | 0.085 | 0.09 | Sphingomyelinase inhibitor | 0.09 0.072 CID_154699859 | CID_154699859 | |
| 0.022 | 0.028 | 0.078 | Sodium/glucose cotransporter 2 inhibitor | 0.078 0.004 CID_154699859 | CID_154699859 | |
| 0.022 | 0.028 | 0.026 | Vanilloid 2 agonist | 0.026 0.016 CID_154699859 | CID_154699859 | |
| 0.09 | 0.098 | 0.148 | Multidrug resistance-associated protein 1 inhibitor | 0.148 0.026 CID_154699859 | CID_154699859 | |
| 0.094 | 0.104 | 0.161 | Microtubule formation inhibitor | 0.161 0.032 CID_154699859 | CID_154699859 | |
| 0.093 | 0.106 | 0.258 | Cell adhesion inhibitor | 0.258 0.014 CID_154699859 | CID_154699859 | |
| 0.043 | 0.057 | 0.073 | Glucose-6-phosphate translocase inhibitor | 0.073 0.014 CID_154699859 | CID_154699859 | |
| 0.203 | 0.219 | 0.538 | Alpha-glucosidase inhibitor | 0.538 0.07 CID_154699859 | CID_154699859 | |
| 0.128 | 0.146 | 0.201 | ATPase inhibitor | 0.201 0.036 CID_154699859 | CID_154699859 | |
| 0.078 | 0.097 | 0.087 | Glutamate release inhibitor | 0.087 0.069 CID_154699859 | CID_154699859 | |
| 0.02 | 0.04 | 0.057 | Sodium/glucose cotransporter inhibitor | 0.057 0.004 CID_154699859 | CID_154699859 | |
| 0.027 | 0.053 | 0.066 | Antibiotic Aminoglycoside-like | 0.066 0.007 CID_154699859 | CID_154699859 | |
| 0.108 | 0.142 | 0.391 | Hemostatic | 0.391 0.008 CID_154699859 | CID_154699859 | |
| 0.046 | 0.08 | 0.081 | Adenine nucleotide translocase inhibitor | 0.081 0.008 CID_154699859 | CID_154699859 | |
| 0.1 | 0.135 | 0.275 | Thrombolytic | 0.275 0.028 CID_154699859 | CID_154699859 | |
| 0.038 | 0.076 | 0.063 | Alpha-mannosidase inhibitor | 0.063 0.023 CID_154699859 | CID_154699859 | |
| 0.03 | 0.074 | 0.052 | Microtubule stabilization | 0.052 0.025 CID_154699859 | CID_154699859 | |
| 0.013 | 0.065 | 0.049 | Protein 30S ribosomal subunit inhibitor | 0.049 0.008 CID_154699859 | CID_154699859 | |
| 0.07 | 0.123 | 0.1 | DNA intercalator | 0.1 0.074 CID_154699859 | CID_154699859 | |
| 0.026 | 0.082 | 0.054 | Mannosidase inhibitor | 0.054 0.021 CID_154699859 | CID_154699859 | |
| 0.009 | 0.072 | 0.033 | Squalene synthetase inhibitor | 0.033 0.022 CID_154699859 | CID_154699859 | |
| 0.045 | 0.111 | 0.062 | Lipocortins synthesis agonist | 0.062 0.031 CID_154699859 | CID_154699859 | |
| 0.027 | 0.094 | 0.104 | Protein 50S ribosomal subunit inhibitor | 0.104 0.012 CID_154699859 | CID_154699859 | |
| 0.143 | 0.213 | 0.343 | Peptidyltransferase inhibitor | 0.343 0.013 CID_154699859 | CID_154699859 | |
| 0.068 | 0.138 | 0.139 | DNA polymerase I inhibitor | 0.139 0.055 CID_154699859 | CID_154699859 | |
| 0.07 | 0.145 | 0.142 | Beta amyloid protein antagonist | 0.142 0.046 CID_154699859 | CID_154699859 | |
| 0.002 | 0.078 | 0.012 | Antibiotic Macrolide-like | 0.012 0.011 CID_154699859 | CID_154699859 | |
| 0.052 | 0.144 | 0.14 | Cell adhesion molecule inhibitor | 0.14 0.017 CID_154699859 | CID_154699859 | |
| 0.1 | 0.2 | 0.158 | Interleukin 6 antagonist | 0.158 0.077 CID_154699859 | CID_154699859 | |
| 0.022 | 0.123 | 0.046 | Neuraminidase (Influenza A) inhibitor | 0.046 0.03 CID_154699859 | CID_154699859 | |
| 0.065 | 0.17 | 0.174 | Toll-Like receptor 4 antagonist | 0.174 0.011 CID_154699859 | CID_154699859 | |
| 0.06 | 0.174 | 0.189 | Beta glucuronidase inhibitor | 0.189 0.014 CID_154699859 | CID_154699859 | |
| 0.042 | 0.166 | 0.088 | Glycine receptor antagonist | 0.088 0.045 CID_154699859 | CID_154699859 | |
| 0.027 | 0.173 | 0.075 | Neuraminidase (influenza) inhibitor | 0.075 0.029 CID_154699859 | CID_154699859 | |
| 0.018 | 0.167 | 0.066 | Neuraminidase inhibitor | 0.066 0.037 CID_154699859 | CID_154699859 | |
| 0.139 | 0.292 | 0.229 | Antiobesity | 0.229 0.177 CID_154699859 | CID_154699859 | |
| 0.072 | 0.229 | 0.176 | Cell wall synthesis inhibitor | 0.176 0.043 CID_154699859 | CID_154699859 | |
| 0.093 | 0.25 | 0.428 | Tumour necrosis factor alpha release inhibitor | 0.428 0.022 CID_154699859 | CID_154699859 | |
| 0.015 | 0.201 | 0.033 | Toll-Like receptor 4 agonist | 0.033 0.009 CID_154699859 | CID_154699859 | |
| 0.096 | 0.343 | 0.227 | Angiogenesis inhibitor | 0.227 0.141 CID_154699859 | CID_154699859 | |
| 0.094 | 0.346 | 0.133 | CC chemokine 6 receptor antagonist | 0.133 0.061 CID_154699859 | CID_154699859 | |
| 0.03 | 0.289 | 0.081 | ATPase (Vacuolar H+) inhibitor | 0.081 0.075 CID_154699859 | CID_154699859 | |
| 0.044 | 0.33 | 0.194 | Anticoagulant | 0.194 0.055 CID_154699859 | CID_154699859 | |
| 0.014 | 0.639 | 0.048 | Factor IXa inhibitor | 0.048 0.04 CID_154699859 | CID_154699859 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |